A ‘Crystal Ball’ to Better Predict COPD Severity in Minority Groups
See how UVA Health research brings the field closer to precision medicine by quantifying genetic risk for African Americans and other minority groups.
UVA Health Among Select Centers to Offer Curative Therapy for Rare Pulmonary Hypertension
Learn how a team of dedicated clinicians brought pulmonary thromboendarterectomy to Virginia.
UVA Health Earns Hard-to-Achieve Top Rating for Lobectomy
See how UVA Health's lung cancer surgeons earned a coveted 3 stars from The Society of Thoracic Surgeons.
UVA Health Pioneered an Imaging Tool Set to Revolutionize How We Diagnose Pulmonary Diseases
As the world’s leader in clinical research of hyperpolarized MRI, UVA is ushering in a new era of diagnostic advancement for pulmonary diseases.
UVA Pulmonology Achieves Impressive CF Patient Outcomes After Transitioning to Telehealth
UVA Adult Cystic Fibrosis Clinic caught the nation’s attention for its successful and quick transition to telehealth.
UVA Pulmonologist Unleashes Precision Medicine to Combat Pulmonary Fibrosis
Imre Noth, MD, helped secure $22 million in NIH and private funding to dramatically alter how idiopathic pulmonary fibrosis (IPF) is diagnosed and treated.
UVA Pulmonology Takes National Lead in Understanding Pandemic’s Toll
UVA pulmonologists established one of the nation's first post-COVID clinics and brings valuable insights into COVID’s longterm toll by tying clinical data to blood biomarkers.
Pregnancy and Pulmonary Arterial Hypertension: Patient Choice and Medical Advice Come Together
A case study highlighting the collaborative care required to help one mother survive a complex pregnancy and delivery.
Get to Know: Pulmonologist Imre Noth, MD, MS
Imre Noth, MD, is an expert on interstitial lung diseases with a special emphasis on idiopathic pulmonary fibrosis. He has joined UVA as chief of the Division of Pulmonary and Critical Care Medicine.
UVA Is Improving the Odds for Lung Transplant Patients
Ex Vivo Lung Perfusion extends the period of time lungs can remain viable outside of the body, giving lung recipients access to lungs in locations beyond the region in which they are listed.